Nanoparticle drug delivery uses tiny engineered carriers to transport medicines through the body and concentrate them near specific cells. This matters because many powerful drugs, such as chemotherapy agents, can harm healthy tissue when they spread everywhere. By packaging a drug inside a particle with a protective shell, doctors and engineers aim to improve treatment while reducing side effects.
These systems combine biology, chemistry, physics, and medical technology.
Key Facts
- Typical drug delivery nanoparticles are about 10 nm to 200 nm in diameter.
- Surface ligands can bind to cell receptors to improve targeting specificity.
- PEG coatings can reduce immune recognition and increase circulation time.
- Drug loading efficiency = mass of drug inside particles / total drug added x 100%.
- Release rate often depends on diffusion, shell breakdown, pH, temperature, or enzymes.
- A common diffusion idea is J = -D(dC/dx), where J is flux and D is the diffusion coefficient.
Vocabulary
- Nanoparticle
- A nanoparticle is a tiny structure, usually between 1 nm and 100 nm in at least one dimension, designed to carry or interact with materials at the molecular scale.
- Targeting ligand
- A targeting ligand is a molecule on the particle surface that binds to a specific receptor on a target cell.
- PEGylation
- PEGylation is the attachment of polyethylene glycol chains to a particle to help it avoid rapid removal by the immune system.
- Controlled release
- Controlled release is the planned delivery of a drug over time instead of releasing the full dose at once.
- Biocompatibility
- Biocompatibility is the ability of a material to work in the body without causing harmful immune reactions or toxicity.
Common Mistakes to Avoid
- Assuming nanoparticles automatically go only to diseased cells is wrong because targeting improves probability, but particles can still reach healthy tissues.
- Ignoring particle size is wrong because size affects blood circulation, tissue penetration, kidney filtration, and uptake by immune cells.
- Treating the shell as just decoration is wrong because the shell controls stability, immune recognition, drug leakage, and release timing.
- Confusing drug loading with delivered dose is wrong because some loaded drug may leak, degrade, or never reach the target tissue.
Practice Questions
- 1 A batch starts with 50 mg of drug, and 35 mg becomes trapped inside nanoparticles. Calculate the drug loading efficiency as a percent.
- 2 A nanoparticle has a diameter of 120 nm. If a cell receptor region is about 2 micrometers wide, how many nanoparticle diameters fit across that region? Use 1 micrometer = 1000 nm.
- 3 Explain why adding both targeting ligands and a PEG-like stealth coating can improve a nanoparticle drug carrier, and describe one tradeoff between these two design features.